Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Exosome RNA Combination for Diagnosing Prostate Cancer: a Prospective, Multicenter Diagnostic Trial

NCT06604130 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT06604130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06604130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Exosome RNA Combination for Diagnosing Prostate Cancer: a Prospective, Multicenter Diagnostic Trial
Lead sponsor
Xijing Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
March 12, 2021
Completion date
December 31, 2026
Enrollment
1,600 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer